A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
ABSTRACT Broadly neutralizing antibodies (bNAbs) can prevent and control an HIV-1 infection, but their breadth is invariably too limited for use as monotherapy. To address this problem, bi- and trispecific antibody-like constructs have been developed. These engineered antibodies typically have great...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/b24d26652273424fb366dd8cdb7de9b5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|